États-Unis · Plateformes & données · MarketBeat

Gilead Sciences (NASDAQ:GILD) Releases Quarterly Earnings Results, Beats Estimates By $0.36 EPS

Publié par MarketBeat · États-Unis il y a 1 h

Gilead Sciences (NASDAQ:GILD - Get Free Report) announced its quarterly earnings data on Thursday. The biopharmaceutical company reported $2.55 EPS for the quarter, topping…

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Gilead Sciences (NASDAQ:GILD) Releases Quarterly Earnings Results, Beats Estimates By $0.36 EPS

À lire aussi

Axt projects Q4 non-GAAP EPS of $0.57-$0.59 as backlog moves above $500M

Alphabet Sheds $500 Billion in a Single Day Despite Cloud Growth of 103%

A Starbucks turnaround is brewing — but perhaps not quickly enough for investors

Bambusa Therapeutics prices upsized IPO at $16 per share

Jensen Huang Says Nvidia Counted All GPUs At Firm Under Probe For Spying For China

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Gilead Sciences (NASDAQ:GILD) Releases Quarterly Earnings Results, Beats Estimates By $0.36 EPS

Partager

À lire aussi

Axt projects Q4 non-GAAP EPS of $0.57-$0.59 as backlog moves above $500M

Alphabet Sheds $500 Billion in a Single Day Despite Cloud Growth of 103%

A Starbucks turnaround is brewing — but perhaps not quickly enough for investors

Bambusa Therapeutics prices upsized IPO at $16 per share

Jensen Huang Says Nvidia Counted All GPUs At Firm Under Probe For Spying For China

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030